Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators

February 7, 2024

https://www.prnewswire.com/news-releases/genprex-expands-nonclinical-programs-into-new-therapeutic-indications-with-research-collaborators-302055802.html

Reqorsa® Therapy May Be Potential Treatment for ALK-Positive Lung Cancer

Three Collaborators Selected to Present Positive Nonclinical Data on Genprex Oncology Program at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read more at prnewswire.com

Related news for (GNPX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.